X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3584) 3584
vidarabine - analogs & derivatives (3314) 3314
male (2250) 2250
female (2090) 2090
middle aged (1886) 1886
hematology (1743) 1743
vidarabine - administration & dosage (1540) 1540
adult (1497) 1497
aged (1396) 1396
vidarabine - therapeutic use (1383) 1383
oncology (1315) 1315
fludarabine (1187) 1187
antineoplastic combined chemotherapy protocols - therapeutic use (976) 976
leukemia, lymphocytic, chronic, b-cell - drug therapy (949) 949
treatment outcome (863) 863
transplantation (730) 730
vidarabine - pharmacology (709) 709
vidarabine - adverse effects (626) 626
antineoplastic agents - therapeutic use (621) 621
transplantation conditioning - methods (613) 613
cyclophosphamide - administration & dosage (581) 581
therapy (564) 564
animals (537) 537
rituximab (532) 532
adolescent (517) 517
immunology (514) 514
transplantation, homologous (475) 475
disease-free survival (437) 437
cyclophosphamide (434) 434
bone-marrow-transplantation (426) 426
chemotherapy (405) 405
chronic lymphocytic-leukemia (402) 402
leukemia (402) 402
remission induction (401) 401
cancer (400) 400
retrospective studies (368) 368
hematopoietic stem cell transplantation (365) 365
aged, 80 and over (361) 361
antineoplastic combined chemotherapy protocols - adverse effects (359) 359
survival analysis (358) 358
chronic lymphocytic leukemia (342) 342
recurrence (334) 334
survival rate (334) 334
hematopoietic stem cell transplantation - methods (327) 327
leukemia, lymphocytic, chronic, b-cell - pathology (327) 327
stem cells (327) 327
child (319) 319
antineoplastic combined chemotherapy protocols - administration & dosage (316) 316
stem-cell transplantation (316) 316
hematopoietic stem cells (310) 310
versus-host-disease (305) 305
care and treatment (303) 303
prognosis (303) 303
young adult (290) 290
follow-up studies (287) 287
antineoplastic agents - pharmacology (284) 284
graft vs host disease - prevention & control (277) 277
immunosuppressive agents - therapeutic use (264) 264
mice (264) 264
transplantation conditioning (264) 264
cytarabine - administration & dosage (263) 263
vidarabine phosphate - analogs & derivatives (260) 260
antineoplastic agents - adverse effects (257) 257
busulfan - administration & dosage (253) 253
hematology, oncology and palliative medicine (253) 253
apoptosis (252) 252
survival (242) 242
health aspects (238) 238
antineoplastic agents (234) 234
risk factors (233) 233
research (231) 231
time factors (231) 231
alemtuzumab (227) 227
cyclophosphamide - therapeutic use (224) 224
acute myeloid-leukemia (223) 223
antineoplastic agents - administration & dosage (221) 221
antibodies, monoclonal - administration & dosage (219) 219
child, preschool (218) 218
hematopoietic stem cell transplantation - adverse effects (216) 216
apoptosis - drug effects (214) 214
combined modality therapy (214) 214
antimitotic agents (209) 209
antibodies, monoclonal, murine-derived (203) 203
cll (201) 201
drug administration schedule (198) 198
lymphoma (195) 195
leukemia, lymphocytic, chronic, b-cell - mortality (194) 194
antibodies, monoclonal - therapeutic use (193) 193
dose-response relationship, drug (193) 193
leukemia, myeloid, acute - drug therapy (192) 192
whole-body irradiation (183) 183
drug resistance, neoplasm (179) 179
acute myelogenous leukemia (178) 178
regimen (174) 174
prospective studies (172) 172
dosage and administration (171) 171
leukemia, lymphocytic, chronic, b-cell - genetics (171) 171
lymphoma, non-hodgkin - drug therapy (171) 171
busulfan (169) 169
graft vs host disease - etiology (168) 168
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3827) 3827
Chinese (69) 69
Japanese (67) 67
French (31) 31
Spanish (24) 24
German (19) 19
Russian (16) 16
Hungarian (10) 10
Czech (7) 7
Polish (7) 7
Dutch (2) 2
Portuguese (2) 2
Romanian (2) 2
Danish (1) 1
Finnish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
British Journal of Haematology, ISSN 0007-1048, 01/2009, Volume 144, Issue 1, pp. 41 - 52
Journal Article
Oncotarget, ISSN 1949-2553, 2016, Volume 7, Issue 38, pp. 62091 - 62106
Journal Article
Biology of Blood and Marrow Transplantation, ISSN 1083-8791, 2014, Volume 20, Issue 11, pp. 1687 - 1695
Journal Article
PloS one, ISSN 1932-6203, 06/2016, Volume 11, Issue 6, p. e0157114
Journal Article
Annals of Hematology, ISSN 0939-5555, 2/2011, Volume 90, Issue 2, pp. 173 - 183
In this study, we attempted to assess the interactions of resveratrol, a natural compound present in various plant species, with the purine analogues fludarabine and cladribine in terms... 
CLL | Medicine & Public Health | Hematology | DNA damage | Purine analogues | Resveratrol | Oncology | Apoptosis | NUCLEOSIDE ANALOGS | PACLITAXEL-INDUCED APOPTOSIS | DNA-DAMAGE | MECHANISMS | CELL-LINES | COMBINATION | S-PHASE ARREST | CLADRIBINE | IN-VITRO | V-H GENES | HEMATOLOGY | Membrane Glycoproteins - metabolism | Apoptosis - drug effects | Humans | Caspase 3 - metabolism | Antineoplastic Agents - therapeutic use | Stilbenes - pharmacology | DNA-Binding Proteins - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | ZAP-70 Protein-Tyrosine Kinase - metabolism | Adult | Antineoplastic Agents - pharmacology | Drug Therapy, Combination | Protein-Serine-Threonine Kinases - metabolism | Tumor Suppressor Proteins - metabolism | Cell Cycle Proteins - metabolism | bcl-2-Associated X Protein - metabolism | Vidarabine - analogs & derivatives | Ataxia Telangiectasia Mutated Proteins | Vidarabine - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - pathology | Cladribine - pharmacology | Vidarabine - pharmacology | Lymphocytes - pathology | Purines - chemistry | Cladribine - therapeutic use | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | Lymphocytes - drug effects | ADP-ribosyl Cyclase 1 - metabolism | Enzyme Activation | Histones - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Medical colleges | Oncology, Experimental | Automated teller machines | Transplantation | Research | Alkaloids | Chronic lymphocytic leukemia | Lymphocytes | Analysis | DNA | Bone marrow | Cancer | Index Medicus | Original
Journal Article
Molecular cancer, ISSN 1476-4598, 2014, Volume 13, Issue 1, pp. 159 - 159
Journal Article
Annals of hematology, ISSN 1432-0584, 2010, Volume 89, Issue 11, pp. 1115 - 1124
.... In this study, we attempted to assess simvastatin, widely used as a cholesterol-lowering drug, both as a single agent and in combination with purine analogs... 
CLL | Medicine & Public Health | Hematology | DNA damage | Simvastatin | Oncology | Apoptosis | Purine analogs | LOVASTATIN | COA REDUCTASE INHIBITORS | NUCLEOSIDE ANALOGS | STATIN USE | MALIGNANT-CELL | PROLIFERATION | INDUCE APOPTOSIS | COMBINATION | MYELOMA CELLS | V-H GENES | HEMATOLOGY | Prognosis | Apoptosis - drug effects | Humans | Caspase 3 - metabolism | Simvastatin - pharmacology | DNA-Binding Proteins - metabolism | Proto-Oncogene Proteins c-bcl-2 - metabolism | ZAP-70 Protein-Tyrosine Kinase - metabolism | Antineoplastic Agents - pharmacology | Protein-Serine-Threonine Kinases - metabolism | Tumor Suppressor Proteins - metabolism | Purines - pharmacology | Tumor Cells, Cultured - drug effects | Cell Cycle Proteins - metabolism | bcl-2-Associated X Protein - metabolism | Vidarabine - analogs & derivatives | Ataxia Telangiectasia Mutated Proteins | Cladribine - pharmacology | Vidarabine - pharmacology | Purines - chemistry | Leukemia, Lymphocytic, Chronic, B-Cell - metabolism | ADP-ribosyl Cyclase 1 - metabolism | Enzyme Activation | Histones - metabolism | Leukemia, Lymphocytic, Chronic, B-Cell - drug therapy | Anticholesteremic Agents - pharmacology | Medical colleges | Oncology, Experimental | Development and progression | Transplantation | Research | Alkaloids | Chronic lymphocytic leukemia | Analysis | DNA | Bone marrow | Cancer | Index Medicus | Original
Journal Article